Expression and clinical significance of B7-H1 and B7-H3 in ovarian carcinoma

Gadducci A, Cosio S, Gargini A. Sex-steroid hormones, gonadotropin and ovarian carcinogenesis:a review of epidemiological and experimental data [J]. Gynecological Endocrinology, 2004(4):216.

Collins M, Ling V, Carreno B M. The B7 family of immuneregulatory ligands [J]. Genome Biology, 2005(6):223.

Sica G L, Choi I H, Zhu G. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity [J]. Immunity, 2003(6):849.

Seliger B, Quandt D. The expression, function, and clinical relevance of B7 family members in cancer [J]. Cancer Immunology, Immunotherapy, 2012(8):1327.

Hamanishi J, Mandai M, Iwasaki M. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer [J]. Proceedings of the National Academy of Sciences of the United States of America, 2007(9):3360.

Inman B A, SeboT J, Frigola X. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata:associations with localized stage progression [J]. Cancer, 2007(8):1499.

Nakanishi J, Wada Y, Matsumoto K. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers [J]. Cancer Immunology, Immunotherapy, 2007(8):1173.

Nomi T, Sho M, Akahori T. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer [J]. Clinical Cancer Research, 2007(7):2151.

Wu C, Zhu Y, Jiang J. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance [J]. Acta Histochemica, 2006(1):19.

Cao Y, Zhang L, Kamimura Y. B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin [J]. Cancer Research, 2011(4):1235.

Zang X, Sullivan P S, Soslow R A. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas [J]. Modern Pathology, 2010(8):1104.

Crispen P L, Sheinin Y, Roth T J. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma [J]. Clinical Cancer Research, 2008, (16):5150.

Sun J, Chen L J, Zhang G B. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma [J]. Cancer Immunology, Immunotherapy, 2010(8):1163.

Wu C P, Jiang J T, Tan M. Relationship between costimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis [J]. World Journal of Gastroenterology, 2006(3):457.

Zang X, Thompson R H, Al-Ahmadie H A. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome [J]. Proceedings of the National Academy of Sciences of the United States of America, 2007, (49):19458.

ZhaoX, ZhangGB, GanWJ. Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma [J]. Oncology Letters, 2013(3):805.